Results
Bharat Parenterals Q2 Revenue Doubles to ₹136.3 Cr
Bharat Parenterals reported unaudited Q2 FY27 standalone and consolidated financial results approved by the board on October 29, 2026.
Consolidated revenue surged 110.9% YoY to ₹136.28 Cr with EBITDA
